Shareholder alert: weisslaw llp investigates biodelivery sciences international, inc.

New york, feb. 15, 2022 /prnewswire/ -- weisslaw llp is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of biodelivery sciences international, inc. ("biodelivery" or the "company") (nasdaq: bdsi), in connection with the proposed acquisition of the company by collegium pharmaceutical, inc. ("collegium") (nasdaq: coll) via a tender offer.  under the terms of the acquisition agreement, the company's shareholders will receive $5.60 in cash for each share of biodelivery common stock that they hold.
BDSI Ratings Summary
BDSI Quant Ranking